CIK 0001576885 · <br>Emerging growth company
Acumen Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ABOS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364108129
- Phone
- 617-344-4190
- Business address
- 1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-06 | Barton Russell Chief Operating Officer | Grant or award 10b5-1 | +49,800 | 139,031 | ||
| 2025-01-06 | Barton Russell Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +74,700 | 74,700 | ||
| 2025-01-06 | Zuga Matt CFO & Chief Business Officer | Grant or award 10b5-1 | +66,800 | 265,010 | ||
| 2025-01-06 | Zuga Matt CFO & Chief Business Officer | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +100,300 | 100,300 | ||
| 2025-01-06 | Siemers Eric Chief Medical Officer | Grant or award 10b5-1 | +66,800 | 173,517 | ||
| 2025-01-06 | Siemers Eric Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +100,300 | 100,300 | ||
| 2025-01-03 | OConnell Daniel Joseph Chief Executive Officer | Sale 10b5-1 | −47,778 | $1.84 | $88K | 454,707 |
| 2025-01-03 | Meisner Derek M Chief Legal Officer & Corp Sec | Sale 10b5-1 | −11,122 | $1.84 | $21K | 97,745 |
| 2025-01-03 | Barton Russell Chief Operating Officer | Sale 10b5-1 | −7,636 | $1.86 | $14K | 89,231 |
| 2025-01-03 | Zuga Matt CFO & Chief Business Officer | Sale 10b5-1 | −13,235 | $1.84 | $24K | 198,210 |
| 2025-01-03 | Siemers Eric Chief Medical Officer | Sale 10b5-1 | −10,859 | $1.85 | $20K | 106,717 |
| 2024-11-05 | Schacterle Amy Chief Regulatory Officer | Grant or award · Employee Stock Option (right to buy) | +340,000 | 340,000 | ||
| 2024-06-10 | Ives Jeffrey L. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2024-06-10 | Stoppel Laura Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2024-06-10 | Stalfort John A III Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2024-06-10 | Porter Derrell Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2024-06-10 | Fountain Nathan B Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2024-06-10 | Drapkin Kimberlee C Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2024-06-10 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-02-01 | Doherty James J. President and CDO | Grant or award · Employee Stock Option (right to buy) | +601,000 | 601,000 |
Page 7 of 13 · 246 trades